Table 2. Numbers of CD3⁺CD56⁺ T lymphocytes in the peripheral blood of patients with AML-1, ALL-1, AML-2, ALL-2, and in healthy controls.

	Healthy controls	AML-1	ALL-1	AML- 2	ALL-2
Proportion	2.72% ± 1.58%	7.90% ± 0.72%*	0.94% ± 0.39%	3.89% ± 0.54%	10.15% ± 2.93%*
Number (× 106/L)	58.9 ± 34.7	206.5 ± 31.2*	13.6 ± 1.64	116.4 ± 31.8	220.9 ± 59.7*

AML-1, acute myeloid leukemia patients with increased (>10 × 10⁹/L) WBC counts at the time of diagnosis; ALL-1, acute lymphocytic leukemia patients with increased (>10 × 10⁹/L) WBC counts at the time of diagnosis; AML-2, acute myeloid leukemia patients with low WBC counts (<10 × 10⁹/L) at diagnosis; ALL-2, acute lymphocytic leukemia patients with low WBC counts (<10 × 10⁹/L) at diagnosis. *P < 0.05 in one-way ANOVA